鶹ýɫƬ

Journal News

Exercise and fatty food: Using plasma proteomics to understand obesity

Kian Kamgar-Parsi
July 15, 2021

During the COVID-19 pandemic, one of Western society’s greatest health problems has continued its decades-long rise: obesity. According to the Centers for Disease Control and Prevention, obesity rates from 1962 to 2016 (from 14% to 40%), with obesity-related health care costs now . While the effects of obesity are easy to see, our understanding of its underlying physiology continues to evolve.

Fat-mouse-445x250.jpg
/Wikimedia Commons
A high-fat diet is known to cause obesity in both mice and humans. New research
highlighting how exercise can prevent high fat diet–induced changes in protein
levels could provide new tools in the fight against obesity.

“Unfortunately, obesity is at epidemic levels in our communities,” Stephen Twigg, an endocrinologist at the University of Sydney, said. “Methods to prevent it, let alone treat it, are still quite lacking.”

Twigg and University of Sydney biochemist Mark Larance, along with an international team of scientists, have sought to characterize the interplay of two key obesity triggers. High-fat diets, or HFD, and lack of exercise both have been implicated in obesity; however, their effect on the plasma proteome (the milieu of soluble proteins within an organism) has not been well characterized. In a recently published in the journal 鶹ýɫƬ & Cellular Proteomics, Larance and Twigg compared mice fed an HFD to those fed a normal diet and subjected to various exercise regimens to elucidate their combined effect on the plasma proteome.

Following 10 weeks on an HFD, nearly 40% of detected plasma proteins in the mice showed changes. These changes were primarily in liver-associated proteins such as aldolase B, or ALDOB (a key sugar-metabolizing enzyme), a finding consistent with the prevalence of liver damage in obese mice and humans. For mice where these changes already had occurred, exercise as treatment after the fact provided little benefit: Only two of the 82 changed proteins were returned to pre-HFD levels. However, in mice that exercised concurrently with the HFD, roughly 20% of the proteins that were altered in the nonexercising mice maintained their healthy baselines. These effects were independent of the type of exercise, with both endurance and high-intensity interval exercise showing similar results.

“This is one of the first unbiased analyses of the response to HFD,” Larance said. “A lot of those changes, we couldn’t have predicted what they would be. I’ve got the feeling that there are definitely proteins in the plasma that are being ignored at the moment that could be more sensitive than some of the current markers of liver damage … For example, ALDOB might be a more sensitive measure (than current clinical markers) both in humans and in mice.”

Despite these exciting discoveries, significant questions remain. “From the most abundant protein to the least abundant protein spans 13 orders of magnitude,” Larance said, noting the difficulty in detecting low-concentration but important protein species. The type of HFD also heavily influences outcomes, with proteins behaving differently based on the types of fats and number of calories eaten. Additionally, as with any study in mice, differences between the specific changes seen in them and in humans are likely.

Despite these limitations, Larance and Twigg’s work provides a significant advance in our understanding of the proteomics of obesity, and if nothing else, as Twigg concluded, “Probably much better to do some exercise rather than none.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Kian Kamgar-Parsi

Kian Kamgar-Parsi received a Ph.D. in biophysics from the University of Michigan and works as a consultant for the pharmaceutical industry.
 

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.